More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]

SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]

GTX635679
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:500-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    HL344
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Castro V, Pérez-Berna AJ, Calvo G, et al. Three-Dimensional Remodeling of SARS-CoV2-Infected Cells Revealed by Cryogenic Soft X-ray Tomography. ACS Nano. 2023,17(22):22708-22721. doi: 10.1021/acsnano.3c07265
    Read this paper
  • Uemura K, Nobori H, Sato A, et al. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses. Proc Natl Acad Sci U S A. 2023,120(42):e2304139120. doi: 10.1073/pnas.2304139120
    Read this paper
  • Imbiakha B, Ezzatpour S, Buchholz DW, et al. Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5. Sci Adv. 2023,9(38):eadj1736. doi: 10.1126/sciadv.adj1736
    Read this paper
  • Pérez-Vargas J, Worrall LJ, Olmstead AD, et al. A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants. Emerg Microbes Infect. 2023,12(2):2246594. doi: 10.1080/22221751.2023.2246594
    Read this paper
  • Andreu S, von Kobbe C, Delgado P, et al. Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo. Front Microbiol. 2023,14:1185504. doi: 10.3389/fmicb.2023.1185504
    Read this paper
  • Cloherty APM, Rader AG, Patel KS, et al. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade. Emerg Microbes Infect. 2023,12(1):2195020. doi: 10.1080/22221751.2023.2195020
    Read this paper
  • Li Z, Hao P, Zhao Z, et al. The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation. Signal Transduct Target Ther. 2023,8(1):53. doi: 10.1038/s41392-023-01335-5
    Read this paper
  • Gonçalves R, Couto J, Ferreirinha P, et al. SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice. iScience. 2023,26(2):105972. doi: 10.1016/j.isci.2023.105972
    Read this paper
  • Yamamoto Y, Nakano Y, Murae M, et al. Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid. Int J Mol Sci. 2022,24(1). doi: 10.3390/ijms24010020
    Read this paper
  • Yamamoto Y, Inoue T, Inoue M, et al. SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Int J Mol Sci. 2022,23(24). doi: 10.3390/ijms232415834
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions